Alphabet Inc., 10% Owner at Prime Medicine, Inc. (PRME), sold 219,573 shares at $15.02 ($2.2M) on 2023-06-16, disclosed to the SEC on 2023-06-20.
Scheduled sale ($2.2M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 66,659 | $0 | 0.0% |
| 2 | $14.92 | 66,659 | $995K | 45.5% |
| 3 | $14.92 | 66,659 | $995K | 45.5% |
| 4 | $0.00 | 6,532 | $0 | 0.0% |
| 5 | $15.02 | 6,532 | $98K | 4.5% |
| 6 | $15.02 | 6,532 |
| $98K |
| 4.5% |
| Total | $9.95 avg | 219,573 | $2.2M | 100% |
| Filing → |
| PRME | SELL | 2023-05-26 | $728K | — | Filing → |
| PRME | SELL | 2023-05-24 | $3.8M | — | Filing → |
| GTLB | BUY | 2023-05-09 | $393K | — | Filing → |